BioCryst to Highlight Patient-focused Research at the 2025 US HAEA National Summit GlobeNewswire July 09, 2025 RESEARCH TRIANGLE PARK, N.C., July 09, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present new findings from patient-focused research highlighting the burden of current treatments for HAE on pediatric patients under […]
Arvinas Announces Retirement of Chief Executive Officer and Succession Plan GlobeNewswire July 09, 2025 – John Houston, Ph.D., Chairperson, CEO and President at Arvinas, Announces Plans to Retire as CEO Upon Appointment of Successor – – Dr. Houston to Remain Chairperson of Arvinas Board of Directors – – Arvinas Board of Directors to Lead Search
InspireMD Announces U.S. Commercial Launch of CGuard(R) Prime Carotid Stent System for the Prevention of Stroke GlobeNewswire July 09, 2025 MIAMI, July 09, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the prevention of stroke, today announced the official commercial launch of the CGuard Prime carotid
Orion Group Holdings to Report Second Quarter 2025 Financial Results on Tuesday, July 29 Conference Call to be held Wednesday, July 30 at 8:00 a.m. Central Time GlobeNewswire July 09, 2025 HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN), a leading specialty construction company, today announced that it will issue
Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025 GlobeNewswire July 09, 2025 NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the
Krystal Biotech Announces First Patient Dosed in Phase 1/2 Trial of KB801 for the Treatment of Neurotrophic Keratitis GlobeNewswire July 09, 2025 Eye drop administration of KB801 designed to enable sustained expression of NGF in the front of the eye Investor call and webcast to be held July 9 at 8:30 am ET to discuss
OTC Markets Group Welcomes Somerset Trust Holding Company to OTCQX GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Somerset Trust Holding Company (OTCQX: SOME) (the “Company”), the holding company of Somerset Trust
OTC Markets Group Welcomes Whitecap Resources Inc. to OTCQX GlobeNewswire July 09, 2025 NEW YORK, July 09, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Whitecap Resources Inc. (TSX: WCP; OTCQX: WCPRF), a leading Canadian oil & natural gas company,
MADD Canada Unveils Roadside Memorial Sign in Niagara-on-the-Lake in Honour of Ashley Marie Vaillancourt Killed in Impaired Driving Crash GlobeNewswire July 09, 2025 OAKVILLE, Ontario, July 09, 2025 (GLOBE NEWSWIRE) — Today, MADD Canada will unveil a new roadside memorial sign in Niagara-on-the-Lake in honour of 34-year-old Ashley Marie Vaillancourt, who was tragically killed in
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861 GlobeNewswire July 09, 2025 NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc.